Download PDF
Dtsch Med Wochenschr 2008; 133(25/26): 1389-1392
DOI: 10.1055/s-2008-1081087
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Endokrinologie 2008

Endocrinology 2008H. Lehnert1 , G. Hintze2
  • 1I. Medizinische Klinik, Universitätsklinikum Schleswig-Holstein
  • 2Medizinische Klinik, Asklepios Klinik Bad Oldesloe
Further Information

Publication History

Publication Date:
13 June 2008 (online)

Also available at
    Permissions and Reprints

Was ist neu?

  • Latente Hypothyreose: Beibehaltung der Normwerte unter enger Kontrolle bei Werten im oberen Bereich. Individuelle Therapieindikation bei metabolischen Risiken.

  • Latente Hyperthyreose: Klare Empfehlung zur Behandlung bei erhöhtem kardiovaskulärem Risiko.

Literatur

  • 1 Biondi B, Cooper D S. The clinical significance of subclinical thyroid dysfunction.  Endocr Rev. 2008;  29 76-131
    Google Scholar
  • 2 Canaris G J, Manowitz N R, Mayor G. et al . Colorado thyroid disease prevalence study.  Arch Int Med. 2000;  160 526-534
    Google Scholar
  • 3 Cappola A R, Fried L P, Arnold A M. et al . Thyroid status, cardiovascular risk and mortality in older adults.  JAMA. 2006;  295 1033-1041
    Google Scholar
  • 4 De Jong F J, den Heijer T, Visser T J. et al . Thyroid hormones, dementia and atrophy of the medial temporal lobe.  J Clin Endocrinol Metab. 2006;  91 2569-2573
    Google Scholar
  • 5 Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.  Clin Endocrinol. 2006;  64 323-329
    Google Scholar
  • 6 Gharib H, Tuttle R M, Baskin H J. et al . Consensus statement: subclinical thyroid dysfunction.  J Clin Endocrinol Metab. 2005;  90 581-585
    Google Scholar
  • 7 Gussekloo J, van Exel E, de Craen A J. et al . Thyroid status, disability and cognitive function, and survival in old age.  JAMA. 2004;  292 2591-2599
    Google Scholar
  • 8 Hollowell J G, Staehling N W, Flanders W B. et al . Serum TSH, T4 and thyroid antibodies in the United States population: National Health and Nutrition Examination Survey (NHANES III).  J Clin Endocrinol Metab. 2002;  87 489-499
    Google Scholar
  • 9 Iervasi G, Molinaro S, Landi P. et al . Association between increased mortality and mild thyroiddysfunction in cardiac ptients.  Arch Int Med. 2007;  167 1526-1532
    Google Scholar
  • 10 Ito M, Arishima T, Kudo T. et al . Effekt of levo-thyroxine replacement on non-high density lipoprotein cholesterol in hypothyroid patients.  J Clin Endocrinol Metab. 2007;  92 608-611
    Google Scholar
  • 11 Jorde R, Waterloo K, Storhaug H. et al . Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroid treatment.  J Clin Endocrinol Metab. 2006;  91 145-153
    Google Scholar
  • 12 Kalmijn S, Mehta K M, Pols H A. et al . Subclinical hyperthyreoidism and the risk of dementia. The Rotterdam Study.  Clin Endocrinol. 2000;  53 733-737
    Google Scholar
  • 13 Kotsis V, Alevizak M, Stabouli S. et al . Hypertension and hypothyreoidism: results from an ambulatory blood pressure monitoring study.  J Hypertens. 2007;  25 993-999
    Google Scholar
  • 14 Nagasaki T, Inaba M, Kumeda Y. et al . Increased pulse wave velocity in subclinical hypothyroidism.  J Clin Endocrinol Metab. 2006;  91 154-158
    Google Scholar
  • 15 National Academy of Clinical Biochemistroy Web Site. NACB Laboratory Medicine Practice Guidelines at: http://www.nacb.org/lmpg/main.stm. 
    Google Scholar
  • 16 Owen P J, Rajiv C, Vinereanu D. et al . Subclinical hypothyroidism, arterial stiffness and myocardial reserve.  J Clin Endocrinol Metab. 2006;  91 2126-2132
    Google Scholar
  • 17 Razvi S, Ingol L, Keeka G. et al . The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: a randomized, cross-over trial.  J Clin Endocrinol Metab. 2007;  92 1715-1723
    Google Scholar
  • 18 Roberts L M, Pattison H, Roalfe A. et al . Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction ?.  Ann Intern Med. 2006;  145 573-581
    Google Scholar
  • 19 Singh S, Duggal J, Molnar J. et al . Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.  Int J Cardiol. 2008;  28 41-48
    Google Scholar
  • 20 Surks M I, Ortiz E, Daniels G H. et al . Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.  JAMA. 2004;  291 228-238
    Google Scholar
  • 21 Völzke H, Lüdemann J, Robinson D M. et al . The prevalence of undiagnosed thyroid disorders in a previously iodine-eficient area.  Thyroid. 2003;  13 803-810
    Google Scholar
  • 22 Völzke H, Schwahn C, Wallaschofski H. et al . The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship?.  J Clin Endocrinol Metab. 2007;  92 2421-2429
    Google Scholar
  • 23 Wilson S, Parle J V, Roberts L M. et al . Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly.  J Clin Enodrinol Metab. 2006;  91 4809-4816
    Google Scholar
  • 24 Zhu D F, Wang Z X, Zhang D R. et al . fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism.  Brain. 2006;  129 2923-2930
    Google Scholar

Prof. Dr. Hendrik Lehnert, MD FRCP

I. Medizinischen Klinik; Universitätsklinikum Schleswig-Holstein Campus Lübeck

Ratzeburger Allee 160

23538 Lübeck

Phone: 0451/500-2306

Fax: 0451/500-3339

Email: Hendrik.Lehnert@uk-sh.de

      >